The diagnosis and classification of scleroderma (systemic sclerosis)

Area of Science:

• Rheumatology
• Dermatology
• Immunology

Background:

• Scleroderma diagnosis is often delayed until skin sclerosis is apparent.
• Early symptoms like Raynaud's phenomenon can precede definitive signs.
• Current diagnostic methods may lead to misdiagnosis in early stages.

Purpose of the Study:

• To present methods for earlier and more accurate scleroderma diagnosis.
• To introduce a simple classification system (Type 1, 2, 3) for scleroderma based on skin sclerosis extent.
• To highlight the clinical value of this new classification.

Main Methods:

• Utilizing Raynaud's phenomenon combined with specific clinical and serological markers for presumptive diagnosis.
• Applying a classification system based on the extent of early skin sclerosis (Type 1, 2, 3).
• Reviewing and contrasting the proposed classification with existing systems.

Main Results:

• The proposed methods can help avoid incorrect early diagnoses of scleroderma.
• The Type 1, 2, and 3 classification provides a clear and clinically useful way to categorize scleroderma extent.
• This classification system is presented as superior to poorly defined existing classifications.

Conclusions:

• Implementing the described diagnostic methods can significantly improve early scleroderma detection.
• The Type 1, 2, 3 classification offers a practical approach to categorizing scleroderma subtypes.
• Accurate early diagnosis and classification are crucial for effective scleroderma management.